CAPPED BONUSZERTIFIKAT - MERCK & CO. Share Price

Certificat

DE000PC67NA1

Real-time Bid/Ask 15:07:34 07/06/2024 BST
102.3 EUR / 102.32 EUR +0.91% Intraday chart for CAPPED BONUSZERTIFIKAT - MERCK & CO.
Current month+1.32%
1 month+0.08%
Date Price Change
07/06/24 101.5 +0.11%
06/06/24 101.4 +0.26%
05/06/24 101.1 +0.40%
04/06/24 100.7 +0.48%
03/06/24 100.2 +0.18%

Delayed Quote Börse Stuttgart

Last update June 07, 2024 at 08:46 am

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC67NA
ISINDE000PC67NA1
Date issued 25/03/2024
Strike 120 $
Maturity 20/06/2025 (378 Days)
Parity 1 : 1
Emission price 97.12
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 102.3
Lowest since issue 98.84
Spread 0.01
Spread %0.01%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
130.5 USD
Average target price
142.7 USD
Spread / Average Target
+9.32%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW